Astrocytoma
📧 Sign up to get email alerts when something new happens for Astrocytoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas [Phase 1]
This update describes a Phase 1 clinical trial evaluating locoregional administration of EGFR/IL13Rα2 Pool-CAR T cells for recurrent or prog…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma [Phase 1]
This Clinical Trial Update describes a Phase 1 study of hypofractionated re-irradiation for good-prognosis recurrent glioblastoma, sponsored…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Tuvusertib in Astrocytoma With ATRX Mutation [Phase 2]
A phase 2 trial of Tuvusertib in astrocytoma with ATRX mutation is currently recruiting. The study is sponsored by Grupo Español de Investig…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma [Phase 1]
Phase 1 study evaluating vorasidenib in combination with pembrolizumab for recurrent or progressive IDH-1 mutant gliomas (astrocytoma and ol…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma [Phase 1]
A Phase 1 trial evaluating the addition of AZD1390 to radiation therapy for newly diagnosed pediatric high-grade gliomas, including diffuse …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 [Phase 1]
Phase 1 clinical trial update on rQNestin34.5v.2 for recurrent malignant glioma, including glioblastoma and related gliomas, with status cur…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma. [Phase 2]
A Phase 2 clinical trial update for pre-radiation chemotherapy in newly diagnosed high-grade gliomas, including glioblastoma, astrocytoma, a…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma [Phase 2]
Phase 2 clinical trial assessing the combination of All-Trans Retinoic Acid (ATRA) with a PD-1 inhibitor in recurrent IDH-mutant glioma; rec…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Venous Thromboembolism Prevention in Outpatients With Glioma [Phase 2]
A Phase 2 clinical trial is updating recruitment status for venous thromboembolism prevention in outpatients with glioma, including glioblas…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. [Phase 1]
Phase 1 trial update on an adenovirus-mediated suicide gene therapy combined with radiotherapy for progressive astrocytoma; the study is cur…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma [NA]
Clinical trial update evaluating an ex vivo drug combination optimization platform for recurrent high-grade astrocytic glioma, currently rec…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Study of How Safe and Effective Tarlatamab is in Brain Cancers [Phase 2]
Phase 2 clinical trial evaluating the safety and effectiveness of tarlatamab in brain cancers is currently recruiting. The study targets ast…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: FearLess in NeuroOncology [NA]
Clinical trial update for FearLess in NeuroOncology indicates the study is currently recruiting for patients with glioblastoma and other pri…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR)
APPEAR is a clinical trial evaluating amino acid PET-based response assessment in IDH-mutant gliomas and is currently recruiting, sponsored …
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Implantable Microdevice In Primary Brain Tumors [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating an implantable microdevice for primary brain tumors is currently recruiting across multiple gliom…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma [NA]
A clinical trial update describes using molecular profiling to tailor treatments for patients with high-grade glioma, aiming to improve indi…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma [NA]
This Columbia University trial assesses adaptive radiotherapy guided by MRI for adults with newly diagnosed high-grade glioma, including gli…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma [Phase 1]
Phase 1 trial evaluating the combination of eflornithine and temozolomide in newly diagnosed glioblastoma or astrocytoma; recruitment is ong…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Study of Olutasidenib and Temozolomide in HGG [Phase 2]
Phase 2 study evaluating olutasidenib in combination with temozolomide for high-grade gliomas is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions. [NA]
A ClinicalTrials.gov study is currently recruiting to investigate neurovascular uncoupling in patients with brain lesions. The study involve…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma [Phase 1]
Phase 1 study assessing safety and pharmacokinetics of oral OKN-007 in adults with recurrent high-grade glioma. The trial includes patients …
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Update on the ProTRAIT proton therapy research infrastructure in neuro-oncology, with ongoing recruitment for several brain tumor conditions…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: USPIO Enhanced MR Imaging in CNS Tumours (UMIC) [NA]
This clinical trial (UMIC) is evaluating USPIO-enhanced MRI for imaging CNS tumors, including vestibular schwannoma, glioma, and astrocytoma…
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: IDH1 and OCT4 in High Grade Astrocytoma
This clinical trial update indicates a study evaluating IDH1 and OCT4 in high-grade astrocytoma is currently recruiting.
-
CLINICAL_TRIALS research · 2023-08-01Clinical Trial Update: Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers [NA]
Feasibility and preliminary efficacy study of a mindfulness-based intervention for children and young adults with high-grade or high-risk ca…